Since foundation in 1959, JEIL has made efforts with a sense of mission to contribute to pharmaceutical industry and our society by development of superior medicines for promoting people's happiness and health. JEIL established own central research laboratory for formulation and synthesis of drugs, followed by successive construction of KGMP factory in 1986. JEIL’s chemical production facilities are entirely controlled by BGMP according to GMP guideline for bulk chemical production related to general, special, and aseptic pharmaceuticals. In 2012, JEIL completed Anti-cancer Plant (API, FDF) and Cephalosporin Plant (API) according to cGMP standard and obtained GMP approval. We are specialized in developing and producing patent terminated products to make first generic in exportable countries and trying to reach customer's needs with current products.